KCT-0809 ophthalmic solution ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
53	Sjogren syndrome	3

53. Sjogren syndrome

---

Clinical trials : 305 /  Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02503163 (ClinicalTrials.gov)	November 23, 2016	17/7/2015	A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome		Dry Eye With Sjögren's Syndrome	Drug: KCT-0809 ophthalmic solution	Kissei Pharmaceutical Co., Ltd.	NULL	Completed	20 Years	N/A	All		Phase 3	Japan
2	NCT02503189 (ClinicalTrials.gov)	November 23, 2016	17/7/2015	A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome		Dry Eye With Sjögren's Syndrome	Drug: KCT-0809 ophthalmic solution;Drug: Placebo	Kissei Pharmaceutical Co., Ltd.	NULL	Completed	20 Years	N/A	All		Phase 3	Japan
3	NCT02503176 (ClinicalTrials.gov)	August 2015	17/7/2015	An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome		Dry Eye With Sjögren's Syndrome	Drug: KCT-0809 ophthalmic solution	Kissei Pharmaceutical Co., Ltd.	NULL	Terminated	20 Years	N/A	All		Phase 3	Japan